TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures

J Neurosci Res. 2001 Apr 15;64(2):121-31. doi: 10.1002/jnr.1059.

Abstract

Primary septo-hippocampal cell cultures were incubated in varying concentrations of tumor necrosis factor (TNF-alpha; 0.3-500 ng/ml) to examine proteolysis of the cytoskeletal protein alpha-spectrin (240 kDa) to a signature 145 kDa fragment by calpain and to the apoptotic-linked 120-kDa fragment by caspase-3. The effects of TNF-alpha incubation on morphology and cell viability were assayed by fluorescein diacetate-propidium iodide (FDA-PI) staining, assays of lactate dehydrogenase (LDH) release, nuclear chromatin alterations (Hoechst 33258), and internucleosomal DNA fragmentation. Incubation with varying concentrations of TNF-alpha produced rapid increases in LDH release and nuclear PI uptake that were sustained over 48 hr. Incubation with 30 ng/ml TNF-alpha yielded maximal, 3-fold, increase in LDH release and was associated with caspase-specific 120-kDa fragment but not calpain-specific 145-kDa fragment as early as 3.5 hr after injury. Incubation with the pan-caspase inhibitor, carbobenzosy- Asp-CH(2)-OC (O)-2-6-dichlorobenzene (Z-D-DCB, 50-140 microM) significantly reduced LDH release produced by TNF-alpha. Apoptotic-associated oligonucleosomal-sized DNA fragmentation on agarose gels was detected from 6 to 72 hr after exposure to TNF-alpha. Histochemical changes included chromatin condensation, nuclear fragmentation, and formation of apoptotic bodies. Results of this study suggest TNF-alpha may induce caspase-3 activation but not calpain activation in septo-hippocampal cultures and that this activation of caspase-3 at least partially contributes to TNF-alpha-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / pharmacology
  • Calpain / analysis
  • Caspase 3
  • Caspase Inhibitors
  • Caspases / metabolism*
  • Cells, Cultured / drug effects
  • Cycloheximide / pharmacology
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA Fragmentation
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Hippocampus / cytology
  • Hippocampus / drug effects*
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Protein Synthesis Inhibitors / pharmacology
  • Rats
  • Septum Pellucidum / cytology
  • Septum Pellucidum / drug effects*
  • Spectrin / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Nerve Tissue Proteins
  • Protein Synthesis Inhibitors
  • Tumor Necrosis Factor-alpha
  • benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene
  • Spectrin
  • Aspartic Acid
  • Cycloheximide
  • Calpain
  • Casp3 protein, rat
  • Caspase 3
  • Caspases